Sumitomo Pharma Market Cap

Sumitomo Pharma has a market cap or net worth of 1.16 trillion as of January 9, 2026. Its market cap has increased by 387.35% in one year.

Market Cap

1.16T

Enterprise Value

1.38T

Revenue

445.21B

Ranking

n/a

PE Ratio

7.47

Stock Price

2,909.50

Market Cap Chart

Since January 14, 1992, Sumitomo Pharma's market cap has increased from 205.93B to 1.16T, an increase of 461.31%. That is a compound annual growth rate of 5.20%.

Market Cap History

Date	Market Cap	% Change
Jan 9, 2026	1.16T	25.52%
Dec 30, 2025	920.92B	311.72%
Dec 30, 2024	223.67B	20.82%
Dec 29, 2023	185.14B	-53.35%
Dec 30, 2022	396.90B	-24.60%
Dec 30, 2021	526.41B	-13.00%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Chugai Pharmaceutical	13.86T
HOYA Corporation	8.45T
Takeda Pharmaceutical Company	8.04T
Daiichi Sankyo Company	6.55T
Otsuka Holdings	4.80T
Astellas Pharma	3.96T
Terumo	3.34T
Shionogi &	2.49T

Market Cap Rankings